Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research

https://doi.org/10.20996/1819-6446-2018-14-4-474-487

Full Text:

Abstract

Aim. To describe the characteristics of the patient with MI who is admitted to a hospital and to characterize the main diagnostic and treatment interventions in clinic.

Material and methods. This study is observational and the part of big international project. It includes a representative sample of patients with MI admitted to 16 clinics in 13 regions of Russian Federation (Arkhangelsk region, Belgorod region, Bryansk region, Tver region, Saratov region, Rostov region, Samara region, the Republic of Tatarstan, Perm region, Tyumen region, Khanty-Mansiysk Autonomous district, Kemerovo region, Altai region). Patients were selected at random from among those experiencing a MI that were alive on the next morning after hospitalization. Enrollment took place from June 2015 to August 2016.

Results. Of 1,128 patients included in the study, 872 were male (77.3%) and 256 females. 21.4% of patients had a previous MI, 8.3% had undergone PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior to hospitalization, 34.6% were obese and 52.1% had a high cholesterol level. Only 40.0% of patients had no contact with the health care system within 12 months before the MI. Every fourth patient (25.1%) had undergone dispensarisation within 12 months before MI, women significantly often than men (33.5% and 22.6%, p<0.001). Initial revascularization was performed in 73.2% of patients, PCI was the initial revascularization attempt in 49.4% of patients, and PCI with stenting in 46.7%.

Conclusion. Patient with a MI in Russian clinics is likely to have had a history of cardiovascular disease, and to have regular contact with the health care system within 12 months before the development of cardiovascular event. We demonstrated the high rates of appropriate MI treatment, without significant gender and age difference (except for thrombolysis), however, there is a reserve for increasing the proportion of patients who are undergoing revascularization.

About the Authors

A. V. Kontsevaya
National Medical Research Center for Preventive Medicine
Russian Federation

Anna V. Kontsevaya – MD, PhD, MSc (LSE), Deputy Director on Science and Analytics

Petroverigsky per. 10, Moscow, 101990 



K. Bates
London School of Hygiene & Tropical Medicine
United Kingdom

Katie Bates – Dr, Research Fellow in Health Systems

Keppel Street, London WC1E 7HT, UK



E. A. Goryachkin
National Medical Research Center for Preventive Medicine
Russian Federation

Evgeny A. Goryachkin – Post-Graduate Student

Petroverigsky per. 10, Moscow, 101990 



N. Bobrova
London School of Hygiene & Tropical Medicine
United Kingdom

Natalia Bobrova – Research Fellow

Keppel Street, London WC1E 7HT, UK

 



L. I. Syromiatnikova
Perm State Medical University named after Academician Ye.A. Vagner
Russian Federation

Liudmila I. Syromiatnikova – MD, PhD, Professor, Chair of Propedeutics of Internal Diseases №1

Petropavlovskaya ul. 26, Perm, 614000



Yu. V. Popova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation

Yulia V. Popova – MD, PhD, Researcher, Department of Promotion of New Cardiological Information Technologies, Research Institute of Cardiology

Bolshaya Kazachia ul. 112, 410012



D. Yu. Platonov
Tver Regional Clinical Hospital
Russian Federation

Dmitry Yu. Platonov – MD, PhD, MPH, Head of Cardiology Department, Tver Regional Clinical Hospital; Head of Chair of Internal Medicine, Faculty for Post-Graduate Education

Peterburgskoe Shosse 105, Tver, 170036 



I. V. Osipova
Altai State Medical University
Russian Federation

Irina V. Osipova – MD, PhD, Professor, Head of Faculty Therapy Chair

Lenina pr. 40, Barnaul, Altai Territory 656038



A. M. Nedbaikin
Bryansk Regional Cardiology Hospital
Russian Federation

Andrei M. Nedbaikin – MD, PhD, Head Physician

Oktyabrskaya ul. 44, Bryansk, 241050 



T. N. Malorodova
Belgorod State National Research University
Russian Federation

Tatyana N. Malorodova – MD, PhD, Associate Professor, Chair of Pharmacology and Clinical Pharmacology, 

Pobedy ul. 85, Belgorod, 308015



O. A. Mirolyubova
Northern State Medical University
Russian Federation

Olga A. Mirolyubova – MD, PhD, Professor, Head of Chair of Faculty Therapy

Troitsky pr. 59, Arkhangelsk, 163001 



D. V. Kryuchkov
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation

Dmitry V. Kryuchkov – MD, PhD, Senior Researcher, Laboratory of Modeling of Management Technologies

Sosnoviy bulvar 6, Kemerovo, 650002 



L. A. Khaisheva
Rostov State Medical University
Russian Federation

Larisa A. Khaisheva – MD, PhD, Professor, Chair of Therapy, Faculty of Advanced Training and Professional Retraining

Nahichevansky per. 29, Rostov-on-Don, 344022 



A. S. Galyavich
Kazan State Medical University
Russian Federation

Albert S. Galyavich – MD, PhD, Professor, Head of Chair of Cardiology, Faculty of Advanced Training and Professional Retraining

Butlerova ul. 49, Kazan, 420012 



M. V. Franz
Khanty-Mansiysk District Clinical Hospital
Russian Federation

Maria Franz – PhD, Head of Cardiology Department, Consultative and Diagnostic Polyclinic

Kalinina ul. 40, Khanty-Mansiysk, 628012



A. Yu. Efanov
Tyumen State Medical University
Russian Federation

Alexey Yu. Efanov– MD, PhD, Associate Professor, Chair of Preventive and Rehabilitation Medicine

Odesskaya ul. 54, Tyumen, 625023



D. V. Duplyakov
Samara Regional Cardiology Clinic
Russian Federation

Dmitry V. Duplyakov – MD, PhD, Medical Director, Samara Regional Cardiology Clinic; Professor, Chair of Cardiology

. Aerodromnaya ul. 43, Samara, 443070 



O. M. Drapkina
National Medical Research Center for Preventive Medicine
Russian Federation

Oksana M. Drapkina – MD, PhD, Professor, Corresponding Member of the Russian Academy of Sciences, Director 

Petroverigsky per. 10, Moscow, 101990 



D. Leon
London School of Hygiene & Tropical Medicine; The Arctic University of Norway
United Kingdom

David Leon – PhD, Professor of Epidemiology

Keppel Street, London WC1E 7HT, UK




M. McKee
London School of Hygiene & Tropical Medicine
United Kingdom

Martin McKee – CBE, MD, DSc, MSc, FRCP, FRCPE, FRCPI, FFPH, FMedSci, Professor of European Public Health

Keppel Street, London WC1E 7HT, UK



References

1. GBD 2013 Mortality and Causes of Death Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2.

2. Kontsevaya A.V., Drapkina O.M., Balanova Y.A., et al. Economic Burden of Cardiovascular Diseases in the Russian Federation in 2016. Rational Pharmacotherapy in Cardiology. 2018;14(2):156-66. (In Russ.) doi: 10.20996/1819-6446-2018-14-2-156-166.

3. Kontsevaya А.V., Shal'nova S.А., Balanova YU.А. et al. Socio-economic gradients of behavioral risk factors in the Russian population (based on the results of the ESSE-RF study). Cardiovascular Therapy and Prevention .2015, 14 (4):59-67. (In Russ.) [

4. Andreev EM, Nolte E, Shkolnikov VM, et al. The evolving pattern of avoidable mortality in Russia. Int J Epidemiol. 2003;32(3):437-46. doi: 10.1093/ije/dyg085.

5. Dégano IR, Salomaa V, Veronesi G, et al. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 2015;101(17):1413-21. doi: 10.1136/heartjnl-2014-307310.

6. Popovich L, Potapchik E, Shishkin S, et al. Russian Federation. Health system review. Health Syst Transit. 2011;13(7):1-190, xiii-xiv.

7. Boytsov S.А., Krivonos O.V., Oshhepkovа E.V. et al. Evaluation of the effectiveness of the implementation of activities, the distribution of the reduction in mortality from vascular diseases, according to monitoring data of the Ministry of Health and Social Development of Russia and the register of ACS. Part 1. Menedzher Zdravookhraneniya. 2010;5:19-29. (In Russ.)

8. Kontsevaya A, Sabgaida T, Ivanova A, et al. How has the management of acute coronary syndrome changed in the Russian Federation during the last 10 years? Health Policy. 2017;121(12):1274-9. doi: 10.1016/j.healthpol.2017.09.018.

9. Samorodskaya I. V., Barbarash O. L., Kashtalap V. V., Starinskaya M. А. Analysis of death rates from myocardial infarction in the Russian Federation in 2006 and 2015. Russian Cardiology Journal 2017;11(151):22-6. (In Russ.) .

10. Boytsov S.A., Dovgalevsky P.Ya., Gridnev V.I., et al., Comparative analysis of the data of Russian and foreign acute coronary syndrome registries, Kardiologicheskij Vestnik. 2010;5(1):82-6. (In Russ.)

11. Èrlih А.D., Gracianskij N.А. Russian registry of acute coronary syndrome "RECORD-3". Characteristics of patients and treatment before discharge from the hospital. Kardiologiia. 2016;56(4):17-24. (In Russ.).

12. Erlikh A.D., Gratsiansky N.A. and participants of the RECORD registry. Registry of acute coronary syndromes RECORD. Characteristics of patients and results of in hospital treatment. Kardiologiya. 2009;7(8):4-12. (In Russ.).

13. Erlikh A.D., Kharchenko M.S., Barbarash O.L. et al. The degree of adherence of the implementation of the guidelines on acute coronary syndrome in clinical practice in Russian hospitals and outcomes during hospitalization (data of registry RECORD-2). Kardiologiya. 2013;1:14-22. (In Russ.).

14. Semenova Y.V., Zagrebelnyy A.V., Kutishenko N.P., et al. Assessment of Changes in Quality of Prehospital Treatment of Patients with Acute Coronary Syndrome in the Last Few Years: LIS-1 vs LIS-3 Registries. Rational Pharmacotherapy in Cardiology. 2017;13(6):827-34. (In Russ).

15. Mаrtsevich S.Yu., Kutishenko N.P., Sichinаvа D.P. et al. A prospective outpatient registry of patients who underwent acute myocardial infarction (PROFILE-IM): study design and first results. Cardiovascular Therapy and Prevention. 2018;1:81-6. (In Russ.)

16. Kontsevaya A, Bobrova N, Barbarash O, et al. The management of acute myocardial infarction in the Russian Federation: protocol for a study of patient pathways [version 2; referees: 2 approved. Wellcome Open Res. 2018;2:89. doi: 10.12688/wellcomeopenres.12478.2.

17. Ehrlikh A. D. Six-month outcomes in patients with acute coronary syndrome included in the Russian registry RECORD-3 Russian Cardiological Journal. 2017;11(151):8-14 (In Russ.).

18. Martsevich S.Yu., Semenova Yu.V., Kutishenko N.P., et al. LIS-3 Register of the Acute Coronary Syndrome: what has Changed in a "Portrait" of a Patient and Short-Term Outcomes of the Disease Compared to LIS-1 Register. Rational Pharmacotherapy in Cardiology. 2017;13(1):63-8. (In Russ).

19. Barbarash O. L. Kashtalap V. V., Bykova I. S. et al. Features of the clinical course and inpatient treatment of patients with acute coronary syndrome with ST-segment elevation depending on sex (according to the Russian register of acute coronary syndrome «RECORD-3»). Russian Cardiology Journal. 2017;6(146):122-31. (In Russ.).

20. Kiselev A.R., Popova Y.V., Posnenkova O.M. et al. Implementation of percutaneous coronary interventions in patients with acute coronary syndrome in Russia and clinical factors influencing decision making. Cor et Vasa. 2014;56:e1-e10.

21. Semenova Yu.V., Kutishenko N.P., Zagrebel'nyj А.V., et al. The influence of prehospital adherence of patients to visiting treatment and prophylactic institutions on the long-term outcomes of acute coronary syndrome: a study of LIS-3. Rational Pharmacotherapy in Cardiology. 2017;13(3):363-9. (In Russ.). doi: 10.20996/1819-6446-2017-13-3-363-369.


For citation:


Kontsevaya A.V., Bates K., Goryachkin E.A., Bobrova N., Syromiatnikova L.I., Popova Y.V., Platonov D.Y., Osipova I.V., Nedbaikin A.M., Malorodova T.N., Mirolyubova O.A., Kryuchkov D.V., Khaisheva L.A., Galyavich A.S., Franz M.V., Efanov A.Y., Duplyakov D.V., Drapkina O.M., Leon D., McKee M. Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research. Rational Pharmacotherapy in Cardiology. 2018;14(4):474-487. (In Russ.) https://doi.org/10.20996/1819-6446-2018-14-4-474-487

Views: 215


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)